Login / Signup

Pharmacovigilance of anti-cancer medicines: opportunities and challenges.

Diana CrestanMarta Paulina TrojniakSara FrancesconGiulia FornasierPaolo Baldo
Published in: Expert opinion on drug safety (2020)
The authors outline some crucial challenges and opportunities that can be useful for pharmacovigilance to keep up with the times and follow the current technological and scientific progress. In addition to the evaluations made by researchers, it will, of course, be necessary to have an equality important concrete response from the institutions and regulatory bodies.
Keyphrases
  • adverse drug
  • drug induced
  • transcription factor
  • emergency department
  • electronic health record